24th Apr 2017 7:00 am |
RNS |
Diagnostics firm take rights to several Affimers |
19th Apr 2017 7:00 am |
RNS |
Avacta to Present at the Shares Spotlight Evening |
12th Apr 2017 7:15 am |
RNS |
Hardman Research: Another important box ticked |
6th Apr 2017 2:23 pm |
RNS |
Holding(s) in Company |
6th Apr 2017 2:23 pm |
RNS |
Holding(s) in Company |
6th Apr 2017 10:22 am |
RNS |
Director/PDMR Shareholding |
3rd Apr 2017 7:00 am |
RNS |
Interim Results for the Period Ended 31 Jan 2017 |
3rd Apr 2017 7:00 am |
RNS |
Results of Immunogenicity Study with Human Samples |
31st Mar 2017 9:31 am |
RNS |
Avacta Presents at Investor Evening Hosted by TPI |
31st Mar 2017 7:00 am |
RNS |
London Growth and Innovation Forum Presentation |
22nd Mar 2017 9:00 am |
RNS |
Avacta to present at the UK Investor Show |
21st Mar 2017 7:15 am |
RNS |
Hardman Research: Low response would be positive! |
30th Jan 2017 7:00 am |
RNS |
Director/PDMR Shareholding |
20th Jan 2017 11:35 am |
RNS |
Result of Annual General Meeting |
20th Jan 2017 7:00 am |
RNS |
Trading Update |
11th Jan 2017 7:00 am |
RNS |
Presenting at London Growth and Innovation Forum |
5th Jan 2017 7:00 am |
RNS |
Director Dealing and Issue of Equity |
20th Dec 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
16th Dec 2016 5:14 pm |
RNS |
Holding(s) in Company |
1st Dec 2016 7:00 am |
RNS |
Notice of AGM, Accounts and Directorate Change |
23rd Nov 2016 7:00 am |
RNS |
Technical Update: Affinity Separation |
7th Nov 2016 7:00 am |
RNS |
Cancer Expert joins Scientific Advisory Board |
2nd Nov 2016 7:00 am |
RNS |
CAR-T Cell Therapy Research Collaboration in US |
1st Nov 2016 7:00 am |
RNS |
Results from first Affimer pre-clinical studies |
21st Oct 2016 11:39 am |
RNS |
Director's Dealing |
17th Oct 2016 1:00 pm |
RNS |
Hardman Research: Great strides to strategic goals |
17th Oct 2016 7:00 am |
RNS |
Prelim Results for the Year Ended 31 July 2016 |
4th Oct 2016 3:28 pm |
RNS |
Issue of Equity |
26th Sep 2016 11:21 am |
RNS |
Notice of Results |
22nd Sep 2016 7:00 am |
RNS |
Positive results from first preclinical studies |
12th Sep 2016 7:00 am |
RNS |
Change of Adviser |
31st Aug 2016 2:17 pm |
RNS |
Change of Registered Office |
16th Aug 2016 7:00 am |
RNS |
New Facilities in Cambridge and Wetherby |
10th Aug 2016 7:00 am |
RNS |
Grant Funding |
3rd Aug 2016 7:00 am |
RNS |
Key Affimer patents to be granted in Europe and US |
1st Aug 2016 7:00 am |
RNS |
Trading Statement |
19th Jul 2016 3:13 pm |
RNS |
Holding(s) in Company |
19th Jul 2016 7:15 am |
RNS |
Hardman report: New Affimer opportunities |
14th Jul 2016 7:00 am |
RNS |
Collaboration with Glythera |
8th Jul 2016 7:00 am |
RNS |
Director/PDMR Shareholding |